Uniplan Investment Counsel’s Sabra Healthcare REIT SBRA Stock Holding History

Uniplan Investment Counsel’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.63M	Sell	237,567 -10,663	-4%	-$212K	0.43%	67
2026 Q1	$4.77M	Sell	248,230 -17,094	-6%	-$337K	0.49%	56
2025 Q4	$5.03M	Sell	265,324 -5,945	-2%	-$110K	0.5%	57
2025 Q3	$5.06M	Buy	271,269 +86,792	+47%	+$1.62M	0.5%	57
2025 Q2	$3.4M	Sell	184,477 -4,056	-2%	-$72K	0.34%	73
2025 Q1	$3.29M	Buy	+188,533	New	+$3.18M	0.32%	84

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Uniplan Investment Counsel's SBRA Position: Q2 2026 in Review

Uniplan Investment Counsel reduced its Sabra Healthcare REIT (SBRA) stake by 4.3% in Q2 2026, selling an estimated $212K and leaving 237,567 shares worth $4.63M. The position accounts for 0.43% of the portfolio, ranked #67.

Uniplan Investment Counsel first reported a position in SBRA in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.06M in Q3 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Uniplan Investment Counsel held 237,567 shares of Sabra Healthcare REIT worth $4.63M as of Q2 2026.
Uniplan Investment Counsel sold 10,663 Sabra Healthcare REIT shares in Q2 2026, an estimated $212K.
Sabra Healthcare REIT made up 0.43% of Uniplan Investment Counsel's portfolio in Q2 2026, its #67 holding.
Uniplan Investment Counsel first reported a position in Sabra Healthcare REIT in Q1 2025 and has held it in 6 quarters since.
Uniplan Investment Counsel's Sabra Healthcare REIT position peaked at $5.06M in Q3 2025.
464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.